SMYD3 and digestive system neoplasm: Similar to SMYD3, other factors that are directly involved in cell cycle regulation, such as cyclins and CDKs, are frequently deregulated in GI tumors and these alterations are correlated with less favorable tumor phenotypes and poor prognosis [55].